blog comments powered by
- This week, Aurobindo Pharma became the first major generic drugmaker to join a patent pool designed to increase accessibility of AIDS/HIV treatments to the poor around the world.
- Lawmakers from across the country have written the Obama Administration in hopes of housing new satellite branches of the Patent and Trademark Office in their respective districts. The America Invents Act, signed into law last month, calls for the creation of three regional offices to help ease a backlog of more than 680,000 pending patent applications.
- Twitter has agreed to drop its lawsuit against Twittad in exchange for the latter’s registered trademark in the word “tweet.” Twitter had previously argued in its legal filings that “tweet” was already famous as a Twitter term before rivals filed trademark applications.
- As part of its bid to acquire Cephalon Inc., Teva Pharmaceutical Industries has been required by the FTC to sell its rights to generic versions of a pain drug and a muscle relaxant to Par Pharmaceutical. Teva must also provide Par with a limited right to market a generic version of Cephalon’s Provigil, a wakefulness drug.
- Google and Samsung have delayed the Nexus Prime over patent fears stemming from litigation already in the works with Apple, which is presently pushing for an injunction to bar Samsung from selling a number of allegedly infringing models in their Galaxy and Infuse product lines.
- In an early win for net neutrality opponents, the D.C. Court of Appeals was recently chosen as the venue for challenges against the FCC’s controversial open Internet order. Verizon filed suit last week against the FCC, characterizing the rules as “arbitrary” and “capricious.”
- Kodak is facing pressure from bondholders seeking to profit from a potential sale of its digital imaging patents. The sale process, which has been in the works since July, seeks to capitalize on appraisals valuing Kodak’s patent portfolio at upwards of $3 billion.